Safety study of an inhaled dry powder in healthy adults
This study tests a new inhaled dry powder medicine (called ICF001) in healthy volunteers to see how safe it is and what side effects it might cause. It is a first-in-human study, so participants will help researchers understand the drug's effects and how it moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in good general health, with no major medical conditions.
- You have not smoked or vaped for at least 3 months before the study.
- Your body mass index (BMI) is between 18 and 32, and your weight is at least 45 kg (about 99 lbs).
- You have no history of lung problems like asthma or COPD, and your breathing test results are normal.
- You are willing to avoid certain foods and drinks (like grapefruit, coffee, and tea) for a while.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled medication called ICF004 in healthy adults to see if it is safe and how the body processes it. It may help in developing a new treatment for lung conditions.
This early-phase study tests an inhaled medication (CHF10136) to see if it's safe and how the body handles it. It includes both healthy adults and people with asthma, and participants will be monitored closely throughout.
This study tests a new inhaled powder (RC010) to see if it is safe and how the body processes it. It is for healthy adults who do not smoke and have no major health problems.
This trial tests a new inhaler medication to see if it is safe and how the body processes it. It may help in future treatments for lung conditions.
This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.